Telemedically Assisted Optimization for Heart Failure Patients Before Cardiac Surgery to Improve Perioperative Outcome
Recruiting
N/A
Interventional Study
Patients With Heart Failure Undergoing Cardiac Surgery
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 162 (estimated)
- Sponsor
- Medical University Innsbruck · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients with heart failure undergoing cardiac surgery face a significantly increased perioperative risk, yet no standardized strategy exists to mitigate this risk effectively. Current preoperative management relies on optimization of medical therapy without a structured prehabilitation approach. Given the strong association between eleveated preoperative N-terminal pro-B-type natriuretic peptide …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Indication for elective cardiac surgery in the Heart team
* NTproBNP ≥ 1500 ng/L
* ≥ 18 years willing to participate in trial
* Written informed consent
Exclusion Criteria:
* Neuropsychiatric disorders / illnesses (e.g. drug addiction, alcohol abuse) that do not allow adhere…
Contacts